Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells
Sushil G. Rane(National Institute of Diabetes and Digestive and Kidney Diseases), E. Premkumar Reddy(The Graduate Center, CUNY), Brian Wong(NewYork–Presbyterian Brooklyn Methodist Hospital), James K. Mangan(UC San Diego Health System), Renu K. Vora(Temple University), Arshad Amanullah(Temple University), Xavier Graña(Temple University), Barbara Hoffman(Temple University), Dan A. Liebermann(American Association For Cancer Research)
Cited by 28
Related Papers
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2019|274
Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey
|BMC Cancer|2016|194
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|192